dr. hwang on treatment selection in metastatic castration-sensitive prostate cancer
Published 4 years ago • 590 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
1:03
dr. hwang on the evolution of treatment in metastatic cspc
-
2:09
dr. hwang on choosing agents for prostate cancer treatment
-
1:22
dr. hwang on the state of treatment in metastatic prostate cancer
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
1:16
dr. hwang on the utility of antiandrogens in metastatic prostate cancer
-
3:06
treatment intensification in metastatic castration-sensitive prostate cancer
-
2:28
dr. yu on treatment intensification in metastatic castration-sensitive prostate cancer
-
5:48
data for metastatic castration-sensitive prostate cancer
-
1:20
dr. hwang on the addition of radium-223 to abiraterone acetate and prednisone in mcrpc
-
1:45
dr. choudhury on antiandrogen treatment selection in nonmetastatic crpc
-
1:37
dr. agarwal on drug development in metastatic castration-sensitive prostate cancer
-
1:46
dr. agarwal on the qol with apalutamide in metastatic castration-sensitive prostate cancer
-
5:39
early treatment intensification for mcspc: optimising patient selection and treatment
-
1:23
dr. bryce on treatment selection in nonmetastatic castration-resistant prostate cancer
-
16:26
patient selection in metastatic hormone-sensitive prostate cancer (mhspc)
-
1:59
considerations in treatment selection
-
1:56
dr. sartor on promising treatment approaches in prostate cancer
-
1:38
dr. morgan on olaparib for metastatic castration-resistant prostate cancer
-
1:24
dr. george on sequential therapy in metastatic prostate cancer